• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center.肝硬化门静脉高压症 TIPS 的临床效果和并发症:单中心研究。
World J Gastroenterol. 2013 Nov 28;19(44):8085-92. doi: 10.3748/wjg.v19.i44.8085.
2
Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.用于经颈静脉肝内门体分流术的膨体聚四氟乙烯覆膜支架移植物的早期和长期临床及影像学随访结果
Eur Radiol. 2004 Oct;14(10):1842-50. doi: 10.1007/s00330-004-2359-4. Epub 2004 Jun 25.
3
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.经颈静脉肝内门体分流术时经皮穿刺左支门静脉以减少肝性脑病。
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088.
4
Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.10mm 覆盖型经颈静脉肝内门体分流术后肝硬化患者的长期临床转归和生存预测因素。
Gastroenterol Hepatol. 2021 Nov;44(9):620-627. doi: 10.1016/j.gastrohep.2020.10.018. Epub 2020 Nov 26.
5
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.经颈静脉肝内门体分流术与门静脉高压相关并发症
World J Gastroenterol. 2014 Dec 7;20(45):16996-7010. doi: 10.3748/wjg.v20.i45.16996.
6
Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.100例患者经颈静脉肝内门体分流术治疗静脉曲张出血后的结局
Am J Gastroenterol. 1997 Sep;92(9):1444-52.
7
Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.门静脉分流支和支架位置可预测经颈静脉肝内门体分流术后的生存情况。
World J Gastroenterol. 2014 Jan 21;20(3):774-85. doi: 10.3748/wjg.v20.i3.774.
8
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.经颈静脉肝内门体分流术(TIPS)在门静脉高压症治疗中的作用。
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500.
9
Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.使用Viatorr膨体聚四氟乙烯覆膜支架移植物建立经颈静脉肝内门体分流术。
J Vasc Interv Radiol. 2004 Mar;15(3):239-48. doi: 10.1097/01.rvi.0000116194.44877.c1.
10
Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience.经颈静脉肝内门体分流术治疗肝硬化门静脉高压症:单中心经验
BMC Surg. 2019 Dec 12;19(1):191. doi: 10.1186/s12893-019-0659-5.

引用本文的文献

1
Influence of different portal vein branches on hepatic encephalopathy during intrahepatic portal shunt jugular vein.肝内门腔静脉分流术时不同门静脉分支对肝性脑病的影响。
World J Gastroenterol. 2022 Aug 21;28(31):4467-4470. doi: 10.3748/wjg.v28.i31.4467.
2
Pediatric liver cirrhosis interventional procedures: from biopsy to transjugular intrahepatic portosystemic shunt.小儿肝硬化介入治疗:从肝活检到经颈静脉肝内门体分流术。
Pediatr Radiol. 2023 Apr;53(4):727-738. doi: 10.1007/s00247-022-05492-7. Epub 2022 Sep 19.
3
Transjugular intrahepatic portosystemic shunt (TIPS) procedure: an assessment of the quality and readability of online information.经颈静脉肝内门体分流术(TIPS)操作:在线信息质量和可读性的评估。
BMC Med Inform Decis Mak. 2021 May 5;21(1):149. doi: 10.1186/s12911-021-01513-x.
4
Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis.使用Viatorr支架的经颈静脉肝内门体分流术对肝硬化患者肝脏储备功能的影响。
World J Clin Cases. 2021 Mar 6;9(7):1532-1542. doi: 10.12998/wjcc.v9.i7.1532.
5
Pathophysiology and Management of Variceal Bleeding.食管胃静脉曲张出血的病理生理学与处理。
Drugs. 2021 Apr;81(6):647-667. doi: 10.1007/s40265-021-01493-2. Epub 2021 Mar 12.
6
Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension.经颈静脉肝内门体分流术治疗肝硬化门静脉高压症的回顾性研究
GE Port J Gastroenterol. 2020 Dec;28(1):5-12. doi: 10.1159/000507894. Epub 2020 Jun 9.
7
Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.经颈静脉肝内门体分流术治疗小儿患者的技术成功率及疗效:20年经验总结
Pediatr Radiol. 2019 Jan;49(1):128-135. doi: 10.1007/s00247-018-4267-9. Epub 2018 Oct 6.
8
Implantability, Complications, and Follow-Up After Transjugular Intrahepatic Portosystemic Stent-Shunt Creation With the 6F Self-Expanding Sinus-SuperFlex-Visual Stent.使用6F自膨式窦道-超柔性-可视支架建立经颈静脉肝内门体分流术后的可植入性、并发症及随访情况
Iran J Radiol. 2016 Feb 17;13(3):e28689. doi: 10.5812/iranjradiol.28689. eCollection 2016 Jul.
9
Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial.覆膜支架与裸支架在经颈静脉肝内门体分流术治疗肝硬化门静脉高压中的疗效:一项单中心随机试验
Sci Rep. 2016 Feb 15;6:21011. doi: 10.1038/srep21011.
10
Contrast enhanced computed tomography and reconstruction of hepatic vascular system for transjugular intrahepatic portal systemic shunt puncture path planning.用于经颈静脉肝内门体分流穿刺路径规划的肝脏血管系统对比增强计算机断层扫描及重建
World J Gastroenterol. 2015 Aug 28;21(32):9623-9. doi: 10.3748/wjg.v21.i32.9623.

本文引用的文献

1
The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009.经颈静脉肝内门体分流术(TIPS)在门静脉高压管理中的作用:2009年更新
Hepatology. 2010 Jan;51(1):306. doi: 10.1002/hep.23383.
2
The transjugular intrahepatic portosystemic shunt (TIPS).经颈静脉肝内门体分流术(TIPS)。
Clin Radiol. 2009 Jul;64(7):664-74. doi: 10.1016/j.crad.2008.09.017. Epub 2009 Feb 13.
3
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.经颈静脉肝内门体分流术联合聚四氟乙烯覆膜支架植入术后肝性脑病的发生率、自然病史及危险因素
Am J Gastroenterol. 2008 Nov;103(11):2738-46. doi: 10.1111/j.1572-0241.2008.02102.x. Epub 2008 Sep 4.
4
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.经颈静脉肝内门体分流术术后肝性脑病:十年经验总结
QJM. 2008 Jun;101(6):493-501. doi: 10.1093/qjmed/hcn037. Epub 2008 Apr 25.
5
Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.使用聚四氟乙烯覆膜支架的经颈静脉肝内门体分流术改善临床结局。
Eur J Gastroenterol Hepatol. 2006 Mar;18(3):225-32. doi: 10.1097/00042737-200603000-00001.
6
TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study.带膨体聚四氟乙烯覆膜支架的经颈静脉肝内门体分流术:一项意大利多中心研究的结果
AJR Am J Roentgenol. 2005 Aug;185(2):472-80. doi: 10.2214/ajr.185.2.01850472.
7
Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.聚四氟乙烯覆膜支架移植物与裸支架治疗经颈静脉肝内门体分流术功能障碍的比较
Eur J Radiol. 2005 Jul;55(1):120-4. doi: 10.1016/j.ejrad.2004.10.007.
8
American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension.美国肝病研究协会实践指南:经颈静脉肝内门体分流术在门静脉高压管理中的作用
J Vasc Interv Radiol. 2005 May;16(5):615-29. doi: 10.1097/01.RVI.0000157297.91510.21.
9
Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.用于经颈静脉肝内门体分流术创建的Viatorr膨体聚四氟乙烯覆膜支架移植物的回顾性多中心试验结果。
J Vasc Interv Radiol. 2004 Nov;15(11):1219-30. doi: 10.1097/01.RVI.0000137434.19522.E5.
10
Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience.用于经颈静脉肝内门体分流术创建的聚四氟乙烯涂层镍钛诺支架移植物:3年经验
Radiology. 2004 Jun;231(3):820-30. doi: 10.1148/radiol.2313030349. Epub 2004 Apr 29.

肝硬化门静脉高压症 TIPS 的临床效果和并发症:单中心研究。

Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center.

机构信息

Jian-Ping Qin, Ming-De Jiang, Wen Tang, Xiao-Ling Wu, Xin Yao, Wei-Zheng Zeng, Hui Xu, Department of Digestion, Chengdu Military General Hospital, Chengdu 610083, Sichuan Province, China.

出版信息

World J Gastroenterol. 2013 Nov 28;19(44):8085-92. doi: 10.3748/wjg.v19.i44.8085.

DOI:10.3748/wjg.v19.i44.8085
PMID:24307804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3848158/
Abstract

AIM

To determine the clinical effects and complications of transjugular intrahepatic portosystemic shunt (TIPS) for portal hypertension due to cirrhosis.

METHODS

Two hundred and eighty patients with portal hypertension due to cirrhosis who underwent TIPS were retrospectively evaluated. Portal trunk pressure was measured before and after surgery. The changes in hemodynamics and the condition of the stent were assessed by ultrasound and the esophageal and fundic veins observed endoscopically.

RESULTS

The success rate of TIPS was 99.3%. The portal trunk pressure was 26.8 ± 3.6 cmH2O after surgery and 46.5 ± 3.4 cmH2O before surgery (P < 0.01). The velocity of blood flow in the portal vein increased. The internal diameters of the portal and splenic veins were reduced. The short-term hemostasis rate was 100%. Esophageal varices disappeared completely in 68% of patients and were obviously reduced in 32%. Varices of the stomach fundus disappeared completely in 80% and were obviously reduced in 20% of patients. Ascites disappeared in 62%, were markedly reduced in 24%, but were still apparent in 14% of patients. The total effective rate of ascites reduction was 86%. Hydrothorax completely disappeared in 100% of patients. The incidence of post-operative stent stenosis was 24% at 12 mo and 34% at 24 mo. The incidence of post-operative hepatic encephalopathy was 12% at 3 mo, 17% at 6 mo and 19% at 12 mo. The incidence of post-operative recurrent hemorrhage was 9% at 12 mo, 19% at 24 mo and 35% at 36 mo. The cumulative survival rate was 86% at 12 mo, 81% at 24 mo, 75% at 36 mo, 57% at 48 mo and 45% at 60 mo.

CONCLUSION

TIPS can effectively lower portal hypertension due to cirrhosis. It is significantly effective for hemorrhage of the digestive tract due to rupture of esophageal and fundic veins and for ascites and hydrothorax caused by portal hypertension.

摘要

目的

探讨经颈静脉肝内门体分流术(TIPS)治疗肝硬化门静脉高压症的临床效果及并发症。

方法

回顾性分析 280 例肝硬化门静脉高压症患者 TIPS 治疗的临床资料。测量手术前后门静脉主干压力,通过超声和食管胃底静脉曲张内镜观察评估血液动力学变化和支架情况。

结果

TIPS 成功率为 99.3%。术后门静脉主干压力为 26.8±3.6cmH2O,术前为 46.5±3.4cmH2O(P<0.01)。门静脉血流速度增加,门静脉、脾静脉内径缩小。近期止血率 100%,食管静脉曲张完全消失 68%,明显减轻 32%;胃底静脉曲张完全消失 80%,明显减轻 20%。腹水消失 62%,明显减少 24%,仍有 14%。腹水减少总有效率为 86%。胸水 100%完全消失。术后 12 个月和 24 个月支架狭窄发生率分别为 24%和 34%。术后肝性脑病发生率分别为 3 个月 12%、6 个月 17%和 12 个月 19%。术后再出血发生率分别为 12 个月 9%、24 个月 19%和 36 个月 35%。12 个月、24 个月、36 个月累积生存率分别为 86%、81%、75%、48 个月 57%和 60 个月 45%。

结论

TIPS 可有效降低肝硬化门静脉高压症患者的门静脉压力,对于食管胃底静脉曲张破裂出血、门静脉高压引起的腹水和胸水具有显著疗效。